Showing 1 - 5 results of 5 for search '"СЕНСОМОТОРНЫЕ НАРУШЕНИЯ"', query time: 0.43s Refine Results
  1. 1
    Academic Journal

    Contributors: This article has been supported by Merz., Статья спонсируется компанией Merz.

    Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 4 (2021); 103-108 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 4 (2021); 103-108 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-4

    File Description: application/pdf

    Relation: https://nnp.ima-press.net/nnp/article/view/1623/1275; Залялова ЗА, Хафизова ИФ, Хаятова ЗГ. Патофизические основы реабилитации при цервикальной дистонии. Фарматека. 2017;15:7-15.; Hallett M. Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis. 2011 May;42(2):177-84. doi:10.1016/j.nbd.2010.08.025. Epub 2010 Sep 15.; Nowak DA, Hermsdorfer J. Predictive and reactive control of grasping forces: on the basal ganglia and sensory feedback. Exp Brain Res. 2006 Sep;173(4):650-60. doi:10.1007/s00221-006-0409-7. Epub 2006 Mar 9.; Barardelli JC, Rothwell JC, Hallett M, et al. The pathophysiology of primary dystonia. Brain. 1998 Jul;121 ( Pt 7):1195-212. doi:10.1093/brain/121.7.1195; Feve A. Physiopathologie de la dystonie. In: Christen Y, Droy-Lefaix MT, Nieoulon A, Rascol O, editors. La plaque neuromusculaire. Marseille: Solal; 1999. P. 151-7.; Westphal CF. Uber eine dem Bilde der cerebrospinalen grauen Degeneration Khnliche Erkrankung des centrlen Nervensystem sohne anatomisschen Befund, nebsteinigen Bemerkungenuber paradoxe Contraction. Arch Psychiatr Nervenkr. 1883;14:87-95.; Foix C, Thevenard A.Les reflexes de posture. Rev Neurol. 1923;30:449-68.; Rondot P, Scherrer J.Reflex contraction induced by passive shortening of the muscle in athetosis and position dystonias. Rev Neurol. 1966 May;114(5):329-37.; Jedynak A, de Saint Victor JF. Treatment of spasmodic torticollis by local injections of botulinum toxin. Rev Neurol (Paris). 1990;146(6-7):440-3 (In French).; Comella C, Bhatia K.An international survey of patients with cervical dystonia. J Neurol. 2015;262(4):837-48. doi:10.1007/s00415-014-7586-2. Epub 2015 Jan 22.; Pagan FL, Harrison A.A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin: a new botulinum neurotoxin A. Parkinsonism Relat Disord. 2012 Jun;18(5):441-5. doi:10.1016/j.parkreldis.2012.02.008. Epub 2012 Mar 9.; Comella CL, Jankovic J, Truong DD, et al; U.S. XEOMIN Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(R), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011 Sep 15;308(1-2):103-9. doi:10.1016/j.jns.2011.05.041. Epub 2011 Jul 18.; Tsui JKC, Stoessl AJ, Eisen A, et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986 Aug 2;2(8501):245-7. doi:10.1016/s0140-6736(86)92070-2; Koller W, Vetere-Overfield B, Gray C, Dubinsky R. Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis. Clin Neuropharmacol. 1990 Aug;13(4):355-8. doi:10.1097/00002826-199008000-00011; Lorentz IT, Subramaniam SS, Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients. Mov Disord. 1991;6(2):145-50. doi:10.1002/mds.870060210; Moore AP, Blumhardt LD. A double blind trial of botulinum toxin «A» in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):813-6. doi:10.1136/jnnp.54.9.813; Lu CS, Chen RS, Tsai CH. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia. J Formos Med Assoc. 1995 Apr;94(4):189-92.; Lew MF, Adornato BT, Duane DD, et al. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 1997 Sep;49(3):701-7. doi:10.1212/wnl.49.3.701; Poewe W, Deuschl G, Nebe A, et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):13-7. doi:10.1136/jnnp.64.1.13; Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology. 1999 Oct 22;53(7):1439-46. doi:10.1212/wnl.53.7.1439; Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology. 1999 Oct 22;53(7):1431-8. doi:10.1212/wnl.53.7.1431; Truong D, Duane DD, Jankovic J, et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005 Jul;20(7):783-91. doi:10.1002/mds.20403; Charles D, Brashear A, Hauser RA, et al. Efficacy, tolerability, and immunogenicity of onabotulinumtoxinA in a randomized, double-blind, placebo-controlled trial for cervical dystonia. Clin Neuropharmacol. Sep-Oct 2012;35(5):208-14. doi:10.1097/WNF.0b013e31826538c7; Benecke R, Jost WH, Kanovsky P, et al. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology. 2005 Jun 14;64(11):1949-51. doi:10.1212/01.WNL.0000163767.99354.C3; Roggenkamper P, Jost WH, Bihari K, et al; NT 201 Blepharospasm Study Team. Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm (Vienna). 2006 Mar;113(3):303-12. doi:10.1007/s00702-005-0323-3. Epub 2005 Jun 15.; Jost WH, Kohl A, Brinkmann S, Comes G. Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers. J Neural Transm (Vienna). 2005 Jul;112(7):905-13. doi:10.1007/s00702-004-0234-8. Epub 2004 Nov 3.; Park J, Lee MS, Harrison AR. Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophtalmol. 2011;5:725-32. doi:10.2147/OPTH.S13978. Epub 2011 Jun 1.; Zoons E, Dijkgraaf MGW, Dijk JM, et al. Botulinum toxin as treatment for focal dystonia: A systematic review of the pharmaco-therapeu-tic and pharmaco-economic value.J Neurol. 2012 Dec;259(12):2519-26. doi:10.1007/s00415-012-6510-x. Epub 2012 May 3.; Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil. 2007 Dec 15;29(23):1761-8. doi:10.1080/09638280701568296; Dressler D, Mander G, Fink K. Measuring the potency labelling of onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) in an LD50 assay. J Neural Transm. 2012 Jan;119(1):13-5. doi:10.1007/s00702-011-0719-1. Epub 2011 Oct 5.; Sethi Kapil D, Rodriguez R, Olayinka B. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ.2012;15(3):419-23. doi:10.3111/13696998.2011.653726. Epub 2012 Jan 18.; Evidente VG, Truong D, Jankovic J, et al. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci.2014;346(1-2):116-20. doi:10.1016/j.jns.2014.08.004; Bleton J-P. Physiotherapy of focal dystonia: a physiotherapists personal experience. Eur J Neurol. 2010 Jul;17 Suppl 1:107-12. doi:10.1111/j.1468-1331.2010.03061.x; Zati A, Cremonini P.Le training autogene de Jacobson dans le traitement du torticolis psychogene. J Readapt Med. 1993;13:3-6.; De Ajuriaguerra J, Garcia Badaracco J, Trillat E, Soubiran G. Treatment of writer's cramp by relaxation: the case process from the tonic experience. Encephale. 1956;2:141-71 (In French).; Schultz JH. Le training autogene. Bibliotheque de psychiatrie. Paris: PUF; 1997.; Meige H, Feindel E. Traitement des tics. Traitement par l'immobilisation des mouve-ments et les mouvements d'immobilisation. Methode de Brissaud. Presse Med. 1901;22:125.; Ramdharry G. Physiotherapy cuts the dose of botulinum toxin. Physiother Res Int. 2006 Jun;11(2):117-22. doi:10.1002/pri.326; Boyce M, Canning C, Mahant N, et al. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehabil. 2013 Mar;27(3):226-35. doi:10.1177/0269215512456221. Epub 2012 Aug 17.; Van den Dool J, Visser B, Koelman JHTM, et al. Long-term specialized physical therapy in cervical dystonia: outcomes of a randomized controlled trial. Arch Phys Med Rehabil. 2019 Aug;100(8):1417-25. doi:10.1016/j.apmr.2019.01.013. Epub 2019 Feb 20.; Korein J, Brudny J. Integrated EMG feedback in the management of spasmodic torticollis and focal dystonia: a prospective study of 80 patients. Res Publ Assoc Res Nerv Ment Dis. 1976;55:385-426.; Bruce L, Bird BL, Catalo MF. Experimental analysis of EMG. Feedback in treating dystonia. Ann Neurol. 1978 Apr;3(4):310-5. doi:10.1002/ana.410030406; Cleeland CS. Behavioral technics in the modification of spasmodic torticollis. Neurology. 1973 Nov;23(11):1241-7. doi:10.1212/wnl.23.11.1241; Bending J, Cleeves L. Effect of electrical nerve stimulation on dystonic tremor. Lancet. 1990 Dec 1;336(8727):1385-6. doi:10.1016/0140-6736(90)92946-f; Tinazzi M, Zarattini S, Valeriani M, et al. Long-lasting modulation of human motor cortex following prolonged transcutaneous electrical nerve stimulation (TENS) of forearm muscles: evidence of reciprocal inhibition and facilitation. Exp Brain Res. 2005 Mar;161(4):457-64. doi:10.1007/s00221-004-2091-y. Epub 2004 Nov 16.; Cavanaugh JA, Platt JV. Retrocollis: management with orthoplast adapted orthosis. Arch Phys Med Rehabil. 1976 Jun;57(6):300-2.; Bleton JP, Vidailhet M, Bourdain F, et al. Somatosensory cortical remodelling after rehabilitation and clinical benefit of in writer's cramp. J Neurol Neurosurg Psychiatry. 2011 May;82(5):574-7. doi:10.1136/jnnp.2009.192476. Epub 2010 Jun 18.

  2. 2
  3. 3
  4. 4
  5. 5